Middle-East OBGYN Graduate Education (MOGGE) Foundation practice guidelines: prevention of group B Streptococcus infection in pregnancy and in newborn. Practice guideline no. 02-O-20

References

• Kwatra G, Cunnington MC, Merrall E, et al. Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(9):1076–1084.
   PubMed Web of Science ®Google Scholar
• Joachim A, Matee MI, Massawe FA, et al. Maternal and neonatal colonisation of group B streptococcus at Muhimbili National Hospital in Dar es Salaam, Tanzania: prevalence, risk factors and antimicrobial resistance. BMC Public Health. 2009; 9(1):437.
   PubMedGoogle Scholar
• Gizachew M, Tiruneh M, Moges F, et al. Proportion of Streptococcus agalactiae vertical transmission and associated risk factors among Ethiopian mother-newborn dyads, Northwest Ethiopia. Sci Rep. 2020;10(1):1–8.
   PubMed Web of Science ®Google Scholar
• Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev. 1998;11(3):497–513.
   PubMed Web of Science ®Google Scholar
• Koenig JM, Keenan W. Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis. Pediatr Clin North Am. 2009; 56(3):689–708.
   PubMed Web of Science ®Google Scholar
• Morgan JA, Cooper DB. Pregnancy, group B streptococcus. StatPearls. edn. 2018.
   Google Scholar
• Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. The Lancet. 2012;379(9815):547–556.
   PubMed Web of Science ®Google Scholar
• Fahmey SS. Early-onset sepsis in a neonatal intensive care unit in Beni Suef, Egypt: bacterial isolates and antibiotic resistance pattern. Korean J Pediatr. 2013;56(8):332–337.
   PubMedGoogle Scholar
• Dangor Z, Lala SG, Cutland CL, et al. Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants. PLOS One. 2015; 10(4):e0123014.
   PubMed Web of Science ®Google Scholar
• Fairlie T, Zell ER, Schrag S. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease. Obstet Gynecol. 2013;121(3):570–577.
   PubMed Web of Science ®Google Scholar
• Walker KF, Morris E, Plumb J, Gray J, et al. Universal testing for group B streptococcus during pregnancy: need for a randomised trial. BJOG. 2020; 127(6):693–693.
   PubMed Web of Science ®Google Scholar
• Shabayek SAAE-K, Abdalla SM, Abouzeid AMH. Abouzeid AM: Vaginal carriage and antibiotic susceptibility profile of group B Streptococcus during late pregnancy in Ismailia, Egypt. J Infect Public Health. 2009; 2(2):86–90.
   PubMedGoogle Scholar
• Mohamed Sadaka S, Abdelsalam Aly H, Ahmed Meheissen M, et al. Group B streptococcal carriage, antimicrobial susceptibility, and virulence related genes among pregnant women in Alexandria, Egypt. Alexandria J Med. 2018; 54(1):69–76.
   Web of Science ®Google Scholar
• Clouse K, Shehabi A, Suleimat AM, et al. High prevalence of Group B Streptococcus colonization among pregnant women in Amman, Jordan. BMC Pregnancy Childbirth. 2019; 19(1):177.
   PubMedGoogle Scholar
• Schrag SJ, Farley MM, Petit S, et al. Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014. Pediatrics. 2016; 138(6):e20162013–e20162013.
   PubMed Web of Science ®Google Scholar
• Vergnano S, Sharland M, Kazembe P, et al. Neonatal sepsis: an international perspective. Arch Dis Child Fetal Neonatal Ed. 2005; 90(3):F220–FF224.
   PubMed Web of Science ®Google Scholar
• Benitz WE, Gould JB, Druzin ML. Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review. J Pediatr. 1999;103(6):e78.
   Google Scholar
• Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev. 2014 Jun 10;(6):CD007467.
   Web of Science ®Google Scholar
• Practice CoO: Committee Opinion Number 279: prevention of early-onset group B streptococcal disease in newborns. J Obstet Gynecol. 2002;100(6):1405–1412.
   Google Scholar
• Money D, Allen VM. No. 298-The prevention of early-onset neonatal group b streptococcal disease. J Obstet Gynaecol Can. 2018;40(8):e665–e674.
   PubMed Web of Science ®Google Scholar
• Hughes RG, Brocklehurst P, Steer PJ, et al. Stenson BM on behalf of the Royal College of Obstetricians and Gynaecologists. Prevention of early-onset neonatal group B streptococcal disease. Green-top GuidelineNo. 36. BJOG. 2017;124:e280–e305.
   PubMed Web of Science ®Google Scholar
• Howick JH. The philosophy of evidence-based medicine. Hoboken, NJ: John Wiley & Sons, Inc.; 2011.
   Google Scholar
• Verani JR, McGee L, Schrag S. Prevention of perinatal group B streptococcal disease. MMWR (Revised Guidelines from CDC, Recommendations Reports). 2010;59(RR10):1–32.
   PubMedGoogle Scholar
• Fultz-Butts K, Gorwitz RJ, Schuchat A, et al. Prevention of perinatal group B streptococcal disease; revised guidelines from CDC. MMWR Morbidity and Mortality Weekly Report 2002;51(No. RR-11):1–22.
   Google Scholar
• Schrag SJ, Zell ER, Lynfield R, Active Bacterial Core Surveillance Team, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med. 2002;347(4):233–239.
   PubMed Web of Science ®Google Scholar
• Royal Australian New Zealand College of Obstetricians and Gynaecologists. Maternal group B Streptococcus in pregnancy: screening and management (C‐Obs 19). In RANZCOG; 2016 [cited 2020 May]. Available from: https://www.ranzcog.edu.au/Statements-Guidelines/
   Google Scholar
• Kurz E, Davis D. Routine culture-based screening versus risk-based management for the prevention of early-onset group B streptococcus disease in the neonate: a systematic review. JBI Database Syst Rev Implement Rep. 2015;13(3):206–246.
   PubMedGoogle Scholar
• UK National Screening Committee. UK NSC group B Streptococcus (GBS) recommendation. London: UK NSC; 2017.
   Google Scholar
• Hasperhoven G, Al‐Nasiry S, Bekker V, et al. Universal screening versus risk‐based protocols for antibiotic prophylaxis during childbirth to prevent early‐onset Group B streptococcal disease: a systematic review and meta‐analysis. BJOG. 2020;127(6):680–691.
   PubMed Web of Science ®Google Scholar
• Middle East Obstetrics and Gynecology Graduate Education (MOGGE) Foundation. GBS prevention campaign (PREV-GBS); 2020 [cited June 2020]. https://www.mogge-obgyn.com/gbs.
   Google Scholar
• Martin JA, Osterman M, Kirmeyer S, et al. Measuring gestational age in vital statistics data: transitioning to the obstetric estimate. Natl Vital Stat Rep. 2015; 64(5):1–20.
   Google Scholar
• Valkenburg-van Den Berg AW, Houtman-Roelofsen RL, Oostvogel PM, et al. Timing of group B streptococcus screening in pregnancy: a systematic review. Gynecol Obstet Invest. 2010;69(3):174–183.
   PubMed Web of Science ®Google Scholar
• Yancey MK, Schuchat A, Brown LK, et al. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol. 1996;88(5):811–815.
   PubMed Web of Science ®Google Scholar
• Spieker MR, White DG, Quist BK. Self-collection of group B streptococcus cultures in pregnant women. Mil Med. 1999; 164(7):471–474.
   PubMed Web of Science ®Google Scholar
• Mercer BM, Taylor MC, Fricke JL, et al. The accuracy and patient preference for self-collected group B Streptococcus cultures. Am J Obstet Gynecol. 1995; 173(4):1325–1328.
   PubMed Web of Science ®Google Scholar
• Price D, Shaw E, Howard M, et al. Self-sampling for group B streptococcus in women 35 to 37 weeks pregnant is accurate and acceptable: a randomized cross-over trial. J Obstet Gynaecol Canada. 2006;28(12):1083–1088.
   PubMedGoogle Scholar
• Seto MT, Ko JK, Cheung KW, et al. The accuracy of self-screening of group B Streptococcus in pregnant women—a randomized crossover study. J Obstet Gynaecol Canada. 2019;41(6):792–797.
   PubMed Web of Science ®Google Scholar
• Bergeron MG, Ke D, Ménard C, et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med. 2000; 343(3):175–179.
   PubMed Web of Science ®Google Scholar
• Feuerschuette OHM, Silveira SK, Cancelier ACL, et al. Diagnostic yield of real-time polymerase chain reaction in the diagnosis of intrapartum maternal rectovaginal colonization by group B Streptococcus: a systematic review with meta-analysis. Diagn Microbiol Infect Dis. 2018; 91(2):99–104.
   PubMed Web of Science ®Google Scholar
• Alfa MJ, Sepehri S, De Gagne P, et al. Real-time PCR assay provides reliable assessment of intrapartum carriage of group B Streptococcus. J Clin Microbiol. 2010; 48(9):3095–3099.
   PubMed Web of Science ®Google Scholar
• El Helali N, Giovangrandi Y, Guyot K, et al. Cost and effectiveness of intrapartum group B streptococcus polymerase chain reaction screening for term deliveries. Obstet Gynecol. 2012;119(4):822–829.
   PubMed Web of Science ®Google Scholar
• Picchiassi E, Coata G, Babucci G, et al. Intrapartum test for detection of Group B Streptococcus colonization during labor. J Matern Fetal Neonatal Med. 2018;31(24):3293–3300.
   PubMed Web of Science ®Google Scholar
• Di Renzo GC, Melin P, Berardi A, et al. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. J Matern Fetal Neonatal Med. 2015;28(7):766–782.
   PubMed Web of Science ®Google Scholar
• Matuszkiewicz-Rowińska J, Małyszko J, Wieliczko M. Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Arch Med Sci. 2015;11(1):67–77.
   PubMed Web of Science ®Google Scholar
• Schwartz B, Schuchat A, Oxtoby MJ, et al. Invasive group B streptococcal disease in adults: a population-based study in metropolitan Atlanta. JAMA Pediatrics. 1991;266(8):1112–1114.
   Google Scholar
• Farkash E, Weintraub AY, Sergienko R, et al. Acute antepartum pyelonephritis in pregnancy: a critical analysis of risk factors and outcomes. Eur J Obstet Gynecol Reprod Biol. 2012;162(1):24–27.
   PubMed Web of Science ®Google Scholar
• Mazor-Dray E, Levy A, Schlaeffer F, et al. Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome? J Matern Fetal Neonatal Med. 2009;22(2):124–128.
   PubMed Web of Science ®Google Scholar
• Ashary N, Singh A, Chhabria K, et al. Meta-analysis on prevalence of vaginal group B streptococcus colonization and preterm births in India. J Mater Fetal Neonat Med 2020 Sep 1:1–9.
   PubMed Web of Science ®Google Scholar
• Anthony BF, Okada DM, Hobel CJ. Epidemiology of group B Streptococcus: longitudinal observations during pregnancy. J Infect Dis. 1978;137(5):524–530.
   PubMed Web of Science ®Google Scholar
• Russell NJ, Seale AC, O'Sullivan C, et al. Risk of early-onset neonatal group B streptococcal disease with maternal colonization worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65(suppl_2):S152–S159.
   PubMed Web of Science ®Google Scholar
• Nanduri SA, Petit S, Smelser C, et al. Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance. JAMA Pediatr. 2019;173(3):224–233.
   PubMed Web of Science ®Google Scholar
• Muller AE, Oostvogel PM, Steegers EA, et al. Morbidity related to maternal group B streptococcal infections. Acta Obstet Gynecol Scand. 2006;85(9):1027–1037.
   PubMed Web of Science ®Google Scholar
• Yoon BH, Romero R, Kim CJ, et al. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol. 1995;172(3):960–970.
   PubMed Web of Science ®Google Scholar
• Blanco JD, Gibbs RS, Castaneda YS. Bacteremia in obstetrics: clinical course. Obstet Gynecol. 1981;58(5):621–625.
   PubMed Web of Science ®Google Scholar
• Jordan HT, Farley MM, Craig A, et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediat Infect Dis J. 2008;27(12):1057–1064.
   PubMed Web of Science ®Google Scholar
• Smaill FM, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 2019;2019(11):CD000490.
   PubMedGoogle Scholar
• Anderson BL, Simhan HN, Simons KM, et al. Untreated asymptomatic group B streptococcal bacteriuria early in pregnancy and chorioamnionitis at delivery. Am J Obstet Gynecol. 2007;196(6):524.e521–524.e525.
   Web of Science ®Google Scholar
• Baecher L, Grobman W. Prenatal antibiotic treatment does not decrease group B Streptococcus colonization at delivery. Int J Gynaecol Obstet. 2008;101(2):125–128.
   PubMed Web of Science ®Google Scholar
• Sharpe M, Shah V, Freire-Lizama T, et al. Effectiveness of oral intake of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on Group B Streptococcus colonization during pregnancy: a midwifery-led double-blind randomized controlled pilot trial. J Mater Fetal Neonat Med. 2019 Aug 13:1–8.
   PubMed Web of Science ®Google Scholar
• Li S, Huang J, Chen Z, et al. Antibiotic prevention for maternal group B streptococcal colonization on neonatal GBS-related adverse outcomes: a meta-analysis. Front Microbiol. 2017;8:374.
   PubMed Web of Science ®Google Scholar
• Turrentine MA, Colicchia LC, Hirsch E, et al. Efficiency of screening for the recurrence of antenatal group B streptococcus colonization in a subsequent pregnancy: a systematic review and meta-analysis with independent patient data. Am J Perinatol. 2016;33(5):510–517.
   PubMed Web of Science ®Google Scholar
• Rottenstreich M, Rotem R, Srebnik N, et al. The recurrence risk of group B Streptococcus in consecutive deliveries. J Mater Fetal Neonat Med. 2020;33(13):2263–2268.
   PubMed Web of Science ®Google Scholar
• De Cueto M, Sanchez M-J, Sampedro A, et al. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol. 1998;91(1):112–114.
   PubMed Web of Science ®Google Scholar
• Lin FYC, Brenner RA, Johnson YR, et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol. 2001;184(6):1204–1210.
   PubMed Web of Science ®Google Scholar
• Illuzzi JL, Bracken MB. Duration of intrapartum prophylaxis for neonatal group B streptococcal disease: a systematic review. Obstet Gynecol. 2006;108(5):1254–1265.
   PubMed Web of Science ®Google Scholar
• Barber EL, Zhao G, Buhimschi IA, et al. Duration of intrapartum prophylaxis and concentration of penicillin G in fetal serum at delivery. J Obstet Gynecol. 2008;112(2):265–270.
   Google Scholar
• Apostol M, Gershman K, Petit S, et al. Trends in perinatal group B streptococcal disease-United States, 2000–2006. MMWR. 2009;58(5):109–112.
   PubMedGoogle Scholar
• Teatero S, Ferrieri P, Martin I, et al. Serotype distribution, population structure, and antimicrobial resistance of group B Streptococcus strains recovered from colonized pregnant women. J Clin Microbiol. 2017;55(2):412–422.
   PubMed Web of Science ®Google Scholar
• Santos NCdS, Oliveira M, Scodro RBdL, et al. Antimicrobial susceptibility of Streptococcus agalactiae isolated from pregnant women. Rev Inst Med Trop Sao Paulo. 2016;58:83.
   PubMed Web of Science ®Google Scholar
• Said M, Dangor Y, Mbelle N, et al. Antimicrobial susceptibility and serotype distribution of Streptococcus agalactiae recto-vaginal colonizing isolates from pregnant women at a tertiary hospital in Pretoria, South Africa: an observational descriptive study letter. BioRxiv. 2019 Jan 1:564856.
   Google Scholar
• Meex C, Douillez S, Kinet-Poleur A, et al. Characterization of Group B Streptococci (GBS) colonizing pregnant women in Belgium, 2018: antimicrobial susceptibility profile and distributions of capsular-types, pili-types and sequence-types. 2020. ECCMID abstract. [cited 2020 May 26] Available from: www.orbi.uliege.be
   Google Scholar
• Lu B, Li D, Cui Y, et al. Epidemiology of Group B streptococcus isolated from pregnant women in Beijing, China. Clin Microbiol Infect. 2014;20(6):O370–O373.
   PubMed Web of Science ®Google Scholar
• Fröhlicher S, Reichen-Fahrni G, Müller M, et al. Serotype distribution and antimicrobial susceptibility of group B streptococci in pregnant women: results from a Swiss tertiary centre. Swiss Med Week. 2014;1112;144.
   Google Scholar
• Burcham LR, Spencer BL, Keeler LR, et al. Determinants of Group B streptococcal virulence potential amongst vaginal clinical isolates from pregnant women. PLOS One. 2019;14(12):e0226699.
   PubMed Web of Science ®Google Scholar
• Woldu ZL, Teklehaimanot TG, Waji ST, Gebremariam MY. The prevalence of Group B Streptococus recto-vaginal colonization and antimicrobial susceptibility pattern in pregnant mothers at two hospitals of Addis Ababa, Ethiopia. Reprod Health. 2014;11(1):80.
   PubMedGoogle Scholar
• Gizachew M, Tiruneh M, Moges F, et al. Streptococcus agalactiae from Ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: alarming for prophylaxis. Ann Clin Microbiol Antimicrob. 2019;18(1):3.
   PubMedGoogle Scholar
• Jisuvei SC, Osoti A, Njeri MA. Prevalence, antimicrobial susceptibility patterns, serotypes and risk factors for group B streptococcus rectovaginal isolates among pregnant women at Kenyatta National Hospital, Kenya; a cross-sectional study. BMC Infect Dis. 2020;20(1):9.
   PubMed Web of Science ®Google Scholar
• Mengist A, Kannan H, Abdissa A. Prevalence and antimicrobial susceptibility pattern of anorectal and vaginal group B Streptococci isolates among pregnant women in Jimma, Ethiopia. BMC Res Notes. 2016;9(1):351.
   PubMedGoogle Scholar
• Gizachew M, Tiruneh M, Moges F, et al. Streptococcus agalactiae maternal colonization, antibiotic resistance and serotype profiles in Africa: a meta-analysis. Ann Clin Microbiol Antimicrob. 2019;18(1):14.
   PubMedGoogle Scholar
• Ji W, Zhang L, Guo Z, et al. Colonization prevalence and antibiotic susceptibility of Group B Streptococcus in pregnant women over a 6-year period in Dongguan, China. PLOS One. 2017;12(8):e0183083.
   PubMed Web of Science ®Google Scholar
• Panda B, Iruretagoyena I, Stiller R, et al. Antibiotic resistance and penicillin tolerance in ano-vaginal group B streptococci. J Mater Fetal Neonat Med. 2009;22(2):111–114.
   PubMed Web of Science ®Google Scholar
• Bhattacharya S. The facts about penicillin allergy: a review. J Adv Pharm Technol Res. 2010;1(1):11–17.
   PubMedGoogle Scholar
• Romano A, Valluzzi RL, Caruso C, et al. Cross-reactivity and tolerability of cephalosporins in patients with IgE-mediated hypersensitivity to penicillins. J Allergy Clin Immunol Pract. 2018;6(5):1662–1672.
   PubMed Web of Science ®Google Scholar
• Briody VA, Albright CM, Has P, et al. Use of cefazolin for group B streptococci prophylaxis in women reporting a penicillin allergy without anaphylaxis. J Obstet Gynecol. 2016;127(3):577–583.
   Google Scholar
• Back EE, O'grady EJ, Back JD. High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital. Antimicrob Agents Chemother. 2012;56(2):739–742.
   PubMed Web of Science ®Google Scholar
• Kabiri D, Hants Y, Yarkoni TR, et al. Antepartum membrane stripping in GBS carriers, is it safe?(the STRIP-G study). PLOS One. 2015;10(12):e0145905.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Prevention of group B streptococcal early-onset disease in newborns: ACOG Committee Opinion, number 782. Obstet Gynecol. 2019;134:206–210.
   PubMed Web of Science ®Google Scholar
• Ohlsson A, Shah VS, Stade BC. Vaginal chlorhexidine during labour to prevent early‐onset neonatal group B streptococcal infection. Cochrane Database Syst Rev. 2014 Dec 14;(12):CD003520.
   Web of Science ®Google Scholar
• Hijona JJ, Carballo AL, Sánchez MS, et al. Vaginal antiseptics reduce the risk of perinatal infection with group B streptococci. J Mater Fetal Neonat Med. 2019;32(16):2741–2745.
   PubMed Web of Science ®Google Scholar